Remepy logo

Remepy

Pioneering hybrid drugs

40 employees · est. 2022 · Israel

VS
Renew Biopharma, Inc. logo

Renew Biopharma, Inc.

Drug discovery using proprietary synthetic biology platform to treat neuroinflammatory conditions.

3 employees · est. 2017 · San Diego, United States

Renew Biopharma, Inc. is the older company (2022 vs 2017); Remepy is the larger of the two.

Side-by-Side Comparison

Remepy Renew Biopharma, Inc.
Founded
2022 2017 older
Headquarters
Israel San Diego, United States
Employees
40 larger 3
Industry
Biotechnology, Health Care Biotechnology, Health Care, Pharmaceutical
Funding Stage
Seed Not tracked yet
Total Funding
$15.00M Not tracked yet
Funding Rounds
2 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Pharma, Biotech, Digital Health, Mobile Apps, Immunology, Drug Development, Oncology, Neurology, Hybrid Drugs, Digital Molecules, Neuroplasticity, Brain Functions, Pharma Partnerships, Treatment Protocols Drug Discovery, Synthetic Biology, Neuroinflammation, Traumatic Brain Injury, Enzymatic Chemistry, Biosynthesis, Medicinal Chemistry, Neurotherapeutics, Blood-Brain-Barrier, Enzymatic Reactions, IP Portfolio, PPAR Receptors, Neurodegenerative Diseases, Cannabinoids
Website
remepy.com renewbiopharma.com
Remepy logo

About Remepy

Remepy is a biotechnology and health care startup founded in 2022, with the slogan "Pioneering hybrid drugs". The company envisions a future where software applications will be an integral part of the treatments offered by pharmaceutical companies in the form of Hybrid Drugs™, combining a software c...

Renew Biopharma, Inc. logo

About Renew Biopharma, Inc.

Renew Biopharma, Inc. is a biotechnology startup with a focus on drug discovery to treat neuroinflammatory conditions. The company has developed a proprietary enzymatic platform through synthetic biology, allowing for the creation of a diverse pipeline of therapeutic molecules, specifically targetin...

We will tell you when either one moves

BounceWatch watches Remepy and Renew Biopharma, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Remepy and Renew Biopharma, Inc. — by email.

Frequently Asked Questions

Remepy — Pioneering hybrid drugs. Renew Biopharma, Inc. — Drug discovery using proprietary synthetic biology platform to treat neuroinflammatory conditions.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Remepy has raised $15.00M while Renew Biopharma, Inc. has raised undisclosed funding.
Remepy and Renew Biopharma, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Remepy with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Remepy on 12 Sep 2024, and Renew Biopharma, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes